Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.7 EUR | -0.93% |
|
-5.26% | -12.20% |
Jul. 15 | BASF SE : UBS maintains a Buy rating | ZD |
Jul. 15 | European companies cut jobs as economy sputters | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.85 for the current period. Therefore, the company is undervalued.
- The company is one of the best yield companies with high dividend expectations.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.20% | 42.51B | - | ||
+13.35% | 83.58B | B | ||
+6.87% | 33.53B | C | ||
+16.94% | 19.3B | B | ||
+11.50% | 11.48B | A- | ||
-12.85% | 9.28B | - | ||
+0.48% | 9.26B | A- | ||
-3.49% | 8.51B | C- | ||
+5.37% | 8.33B | B | ||
-14.54% | 5.68B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BAS Stock
- BASA Stock
- Ratings BASF SE